Injectable biologics have some of the heaviest regulations of any pharmaceutical therapy. The US Food and Drug Administration (FDA) insists that anti-contamination protocols be followed throughout the manufacturing and packaging processes, with all personnel, equipment, and manufacturing and lab environments kept completely sterile. Compliance with good laboratory practices (GLP) and good manufacturing practices (GMP) is [...]The post Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain appeared first on VxP Pharma.